Just curious as to what perspective they (consumer reps) represent. I wouldn't disagree with the data being mediocre but in a disease with nothing mediocre IMO beats nothing.
You sound like you already see their 4-sale sign :-).
I tend to agree about not much value on their HCV but I want to see the Phase 2 data (safety in particular) before firmly concluding that.
Market Data 
Markets 
AI
